Investigating New Mechanisms of Acquired Resistance to Targeted Therapies: If You Hit Them Harder, Do They Get Up Differently?

Cancer Res 2020 Jan;80(1):25-26

Philips Institute for Oral Health Research, VCU School of Dentistry and Massey Cancer Center, Richmond, Virginia.

Targeted therapies have revolutionized treatment of several different types of cancers. However, in almost an invariable fashion, cancers eventually regrow in the presence of the targeted therapy, a phenomenon referred to as acquired resistance. In this issue of , Finn and colleagues demonstrate that modeling acquired resistance to MET tyrosine kinase inhibition in a -amplified gastric cancer cell line by a single, high exposure of the targeted therapy reveals clinically relevant acquired resistant mechanisms, which may be more faithful and comprehensive than the ones revealed through traditional ramp-up approaches..

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-19-3405DOI Listing
January 2020

Publication Analysis

Top Keywords

acquired resistance
12
targeted therapy
8
targeted therapies
8
issue finn
4
acquired resistant
4
finn colleagues
4
relevant acquired
4
clinically relevant
4
colleagues demonstrate
4
resistance issue
4
referred acquired
4
regrow presence
4
mechanisms faithful
4
therapy phenomenon
4
resistant mechanisms
4
phenomenon referred
4
demonstrate modeling
4
resistance met
4
high exposure
4
-amplified gastric
4

Similar Publications